ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Dr. Reddy's Laboratories at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Dr. Reddy's Laboratories brings 2 presentations to ACR Convergence 2026 in Orlando. Its program centres on a proposed abatacept biosimilar for rheumatoid arthritis, comparing immunogenicity, safety and efficacy against the reference drug by subcutaneous and intravenous routes.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
DR Dr. Reddy's Laboratories | |
A pharmaceutical company that develops and manufactures medicines, including biosimilars. | Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Find decision makers at Dr. Reddy's Laboratories
Tell us what you sell and we’ll find the people at Dr. Reddy's Laboratories most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction